Report cover image

Veterinary Dermatology Drugs Market

Publisher Coherent Market Insights
Published Jul 09, 2025
Length 168 Pages
SKU # CMI20302977

Description

Veterinary dermatology drugs are therapeutics used for the treatment of skin diseases in animals. These drugs are formulated to treat skin cancer, bacterial infections, and parasitic infestations. The emergence of enhanced veterinary medical services has enabled veterinarians to offer a wide range of treatment options for various chronic and infectious diseases. These technologies have made veterinary medical services more convenient and cost-effective for both veterinarians and pet owners.

Market Dynamics

The veterinary dermatology drugs market is expected to witness significant growth in the future due to the rising awareness about animal health among pet owners. Additionally, changes in the ecology of parasite habitat, climate change, increase in vector-host interactions, the introduction of foreign species in endemic areas, and high risk of vector-borne infection outside traditional endemic areas are also expected to drive the global veterinary dermatology drugs market growth. Moreover, advancements in technology for better molecular diagnostics and treatments are further anticipated to propel veterinary dermatology drug market growth.

On the contrary, strict approval regulations and side effects associated with the drugs are expected to restrict market growth.

Key features of the study
  • This report provides in-depth analysis of the global veterinary dermatology drugs market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global veterinary dermatology drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Bayer AG, Ceva Sante Animale, Kindred Biosciences, Inc., and IDEXX Laboratories, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global veterinary dermatology drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary dermatology drugs market.
Market Segmentation
  • Global Veterinary Dermatology Drugs Market, By Type of Drug
  • Antibiotics
  • Antifungal drugs
  • Anti-inflammatory drugs
  • Immunotherapy drugs
  • Parasiticides
  • Others
  • Global Veterinary Dermatology Drugs Market, By Animal Type
  • Dogs
  • Cats
  • Horses
  • Others
  • Global Veterinary Dermatology Drugs Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Company Profiles
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Bayer AG
  • Ceva Sante Animale
  • Kindred Biosciences, Inc.
  • IDEXX Laboratories, Inc.

Table of Contents

168 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type of Drug
Market Snapshot, By Animal Type
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Growing prevalence of skin disease in animals
Rise in number of pet owners
Restraints
Lack of awareness across developing countries
Side-effects associated with drugs
Strict approval regulations
Opportunities
Increasing investment by government and private sectors
Development of cutting-edge therapies
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Veterinary Dermatology Drugs Market , By Type of Drug, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Antibiotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Antifungal drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Anti-inflammatory drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Immunotherapy drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Parasiticides
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Bn)
5. Global Veterinary Dermatology Drugs Market , By Animal Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Dogs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Billion)
Cats
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Billion)
Horses
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Billion)
6. Global Veterinary Dermatology Drugs Market , By Region, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, By Country, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Country 2021 –2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(USD Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2032,(USD Bn)
GCC Countries
Israel
South Africa
North Africa
Central Africa
7. Competitive Landscape
Zoetis Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Elanco Animal Health Incorporated
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Boehringer Ingelheim International GmbH
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Virbac
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Vetoquinol S.A.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Dechra Pharmaceuticals PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Ceva Sante Animale
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Kindred Biosciences, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
IDEXX Laboratories, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
8. Section
Research Methodology
About us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us